On the other hand, GM6001 and another MMP inhibitor, minocycline, were reported to efficiently reduce upregulated MMP-2 and MMP-9 and prevent inflammation and oxidative stress associated with cerebral amyloid angiopathy in AD mice [61, 62]. The gene discussed is MMP2; the disease is cerebral amyloid angiopathy.